Difference between revisions of "HemOnc.org - A Hematology Oncology Wiki:About"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 8: Line 8:
 
#Creating a list of chemotherapeutic regimens and common order sets.
 
#Creating a list of chemotherapeutic regimens and common order sets.
 
#Creating checklists that can be used for patients starting therapy with particular regimens.  Areas of focus will include: informed consent/discussion of side effects, supportive medications, dose/schedule adjustments, and the chemotherapy orders themselves.
 
#Creating checklists that can be used for patients starting therapy with particular regimens.  Areas of focus will include: informed consent/discussion of side effects, supportive medications, dose/schedule adjustments, and the chemotherapy orders themselves.
 +
 +
Oncology issues are ever-changing, and I believe that the collaborative efforts of a group of dedicated contributors can result in a far more useful resource than one maintained by a sole person or one which cannot be accessed from virtually any computer with internet access.
  
 
Copyright issues will need to be considered for all entries.
 
Copyright issues will need to be considered for all entries.
Line 13: Line 15:
 
If you would like to participate, please contact me so that an account can be set up.   
 
If you would like to participate, please contact me so that an account can be set up.   
  
- ''[http://onc.dryang.org/index.php?title=User:Dryang Peter Yang]''
+
- ''[http://onc.dryang.org/index.php?title=User:Peter Yang Peter Yang]''

Revision as of 18:31, 12 November 2011

About this Oncology Wiki

This is a project that I have undertaken as of 11/11/11 in an attempt to create a reference for hematology/oncology professionals. Priorities of this project will initially consist of:

  1. Creating a database of chemotherapeutic agents.
  2. Creating an index of diseases.
  3. Creating a list of active clinical trials at BIDMC that can be used by current providers.
  4. Creating a list of chemotherapeutic regimens and common order sets.
  5. Creating checklists that can be used for patients starting therapy with particular regimens. Areas of focus will include: informed consent/discussion of side effects, supportive medications, dose/schedule adjustments, and the chemotherapy orders themselves.

Oncology issues are ever-changing, and I believe that the collaborative efforts of a group of dedicated contributors can result in a far more useful resource than one maintained by a sole person or one which cannot be accessed from virtually any computer with internet access.

Copyright issues will need to be considered for all entries.

If you would like to participate, please contact me so that an account can be set up.

- Yang Peter Yang